Effects of a Remote Multimodal Intervention Involving Diet, Walking Program, and Breathing Exercise on Quality of Life Among Newly Diagnosed People with Multiple Sclerosis: A Quasi-Experimental Non-Inferiority Pilot Study

References

• Walton C, King R, Rechtman L, et al. Rising prevalence of multiple sclerosis worldwide: insights from the Atlas of MS, third edition. Mult Scler. 2020;26(14):1816–1821. doi:10.1177/1352458520970841
   PubMed Web of Science ®Google Scholar
• Thompson AJ, Banwell BL, Barkhof F, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162–173. doi:10.1016/S1474-4422(17)30470-2
   PubMed Web of Science ®Google Scholar
• Goodin DS. The epidemiology of multiple sclerosis: insights to disease pathogenesis. Handb Clin Neurol. 2014;122:231–266. doi:10.1016/B978-0-444-52001-2.00010-8
   PubMedGoogle Scholar
• Dobson R, Giovannoni G. Multiple sclerosis - A review. Eur J Neurol. 2019;26(1):27–40. doi:10.1111/ene.13819
   PubMed Web of Science ®Google Scholar
• Thompson AJ, Baranzini SE, Geurts J, Hemmer B, Ciccarelli O. Multiple sclerosis. Lancet. 2018;391(10130):1622–1636. doi:10.1016/S0140-6736(18)30481-1
   PubMed Web of Science ®Google Scholar
• Stratos K, McGarragle K, Thistle J, Vyas MV, Lee L. Non-compliance with disease modifying therapies in patients with Multiple Sclerosis: a qualitative analysis. Mult Scler Relat Disord. 2020;41:102016. doi:10.1016/j.msard.2020.102016
   PubMed Web of Science ®Google Scholar
• Hartung DM, Bourdette DN, Ahmed SM, Whitham RH. The cost of multiple sclerosis drugs in the US and the pharmaceutical industry: too big to fail? Neurology. 2015;84(21):2185–2192. doi:10.1212/WNL.0000000000001608
   PubMed Web of Science ®Google Scholar
• Wang G, Marrie RA, Salter AR, et al. Health insurance affects the use of disease-modifying therapy in multiple sclerosis. Neurology. 2016;87(4):365–374. doi:10.1212/WNL.0000000000002887
   PubMed Web of Science ®Google Scholar
• Dunn M, Bhargava P, Kalb R. Your patients with multiple sclerosis have set wellness as a high priority-and the national multiple sclerosis society is responding. US Neurol. 2015;11(2):80–86.
   Google Scholar
• Silbermann E, Senders A, Wooliscroft L, et al. Cross-sectional survey of complementary and alternative medicine used in Oregon and Southwest Washington to treat multiple sclerosis: a 17-Year update. Mult Scler Relat Disord. 2020;41:102041. doi:10.1016/j.msard.2020.102041
   PubMed Web of Science ®Google Scholar
• Kalb R, Brown TR, Coote S, et al. Exercise and lifestyle physical activity recommendations for people with multiple sclerosis throughout the disease course. Mult Scler. 2020;26(12):1459–1469. doi:10.1177/1352458520915629
   PubMed Web of Science ®Google Scholar
• Li G, You Q, Hou X, et al. The effect of exercise on cognitive function in people with multiple sclerosis: a systematic review and meta-analysis of randomized controlled trials. J Neurol. 2023;270(6):2908–2923. doi:10.1007/s00415-023-11649-7
   PubMed Web of Science ®Google Scholar
• Dalgas U, Stenager E, Sloth M, Stenager E. The effect of exercise on depressive symptoms in multiple sclerosis based on a meta-analysis and critical review of the literature. Eur J Neurol. 2015;22(3):443–e34. doi:10.1111/ene.12576
   PubMed Web of Science ®Google Scholar
• Flores VA, Šilić P, DuBose NG, Zheng P, Jeng B, Motl RW. Effects of aerobic, resistance, and combined exercise training on health-related quality of life in multiple sclerosis: systematic review and meta-analysis. Mult Scler Relat Disord. 2023;75:104746. doi:10.1016/j.msard.2023.104746
   PubMed Web of Science ®Google Scholar
• Gilbertson RM, Klatt MD. Mindfulness in motion for people with multiple sclerosis: a feasibility study. Int J MS Care. 2017;19(5):225–231. doi:10.7224/1537-2073.2015-095
   PubMedGoogle Scholar
• Manglani HR, Samimy S, Schirda B, Nicholas JA, Prakash RS. Effects of 4-week mindfulness training versus adaptive cognitive training on processing speed and working memory in multiple sclerosis. Neuropsychology. 2020;34(5):591–604. doi:10.1037/neu0000633
   PubMed Web of Science ®Google Scholar
• Schirda B, Duraney E, Lee HK, et al. Mindfulness training for emotion dysregulation in multiple sclerosis: a pilot randomized controlled trial. Rehabilitation Psychology. 2020;65(3):206–218. doi:10.1037/rep0000324
   PubMed Web of Science ®Google Scholar
• Evans E, Levasseur V, Cross AH, Piccio L. An overview of the current state of evidence for the role of specific diets in multiple sclerosis. Mult Scler Relat Disord. 2019;36:101393. doi:10.1016/j.msard.2019.101393
   PubMed Web of Science ®Google Scholar
• Snetselaar LG, Cheek JJ, Fox SS, et al. Efficacy of diet on fatigue and quality of life in multiple sclerosis: a systematic review and Network Meta-analysis of Randomized Trials. Neurology. 2023;100(4):e357–e366. doi:10.1212/WNL.0000000000201371.
   PubMed Web of Science ®Google Scholar
• Wahls TL, Titcomb TJ, Bisht B, et al. Impact of the Swank and Wahls elimination dietary interventions on fatigue and quality of life in relapsing-remitting multiple sclerosis: the WAVES randomized parallel-arm clinical trial. Mult Scler J Exp Transl Clin. 2021;7(3):20552173211035399. doi:10.1177/20552173211035399
   Google Scholar
• Bisht B, Darling WG, White EC, et al. Effects of a multimodal intervention on gait and balance of subjects with progressive multiple sclerosis: a prospective longitudinal pilot study. Degener Neurol Neuromuscul Dis. 2017;7:79–93. doi:10.2147/dnnd.S128872
   PubMed Web of Science ®Google Scholar
• Fellows maxwell K, Wahls T, Browne RW, et al. Lipid profile is associated with decreased fatigue in individuals with progressive multiple sclerosis following a diet-based intervention: results from a pilot study. PLoS One. 2019;14(6):e0218075. doi:10.1371/journal.pone.0218075
   PubMed Web of Science ®Google Scholar
• Lee JE, Bisht B, Hall MJ, et al. A multimodal, nonpharmacologic intervention improves mood and cognitive function in people with multiple sclerosis. J Am Coll Nutr. 2017;36(3):150–168. doi:10.1080/07315724.2016.1255160
   PubMed Web of Science ®Google Scholar
• Bärnighausen T, Tugwell P, Røttingen JA, et al. Quasi-experimental study designs series-paper 4: uses and value. J Clin Epidemiol. 2017;89:21–29. doi:10.1016/j.jclinepi.2017.03.012
   PubMed Web of Science ®Google Scholar
• Pfeiffer E. A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J Am Geriatr Soc. 1975;23(10):433–441. doi:10.1111/j.1532-5415.1975.tb00927.x
   PubMed Web of Science ®Google Scholar
• Hertzog MA. Considerations in determining sample size for pilot studies. Research in Nursing & Health. 2008;31(2):180–191. doi:10.1002/nur.20247
   PubMed Web of Science ®Google Scholar
• Miller WR, Rose GS. Toward a theory of motivational interviewing. Am Psychol. 2009;64(6):527–537. doi:10.1037/a0016830
   PubMed Web of Science ®Google Scholar
• Patrick H, Williams GC. Self-determination theory: its application to health behavior and complementarity with motivational interviewing. Int J Behav Nutr Phys Act. 2012;9:18. doi:10.1186/1479-5868-9-18
   PubMed Web of Science ®Google Scholar
• Deci EL, Ryan RM. The “what” and “why” of goal pursuits: human needs and the self-determination of behavior. PSYCHOL INQ. 2000;11(4):227–268. doi:10.1207/S15327965PLI1104_01
   Web of Science ®Google Scholar
• Harris PA, Taylor R, Minor BL, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208. doi:10.1016/j.jbi.2019.103208
   PubMed Web of Science ®Google Scholar
• Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–381. doi:10.1016/j.jbi.2008.08.010
   PubMed Web of Science ®Google Scholar
• Vickrey BG, Hays RD, Harooni R, Myers LW, Ellison GW. A health-related quality of life measure for multiple sclerosis. Qual Life Res. 1995;4(3):187–206. doi:10.1007/BF02260859
   PubMed Web of Science ®Google Scholar
• Myers J, Bader D, Madhavan R, Froelicher V. Validation of a specific activity questionnaire to estimate exercise tolerance in patients referred for exercise testing. Am Heart J. 2001;142(6):1041–1046. doi:10.1067/mhj.2001.118740
   PubMed Web of Science ®Google Scholar
• Watson TM, Ford E, Worthington E, Lincoln NB. Validation of mood measures for people with multiple sclerosis. Int J MS Care. 2014;16(2):105–109. doi:10.7224/1537-2073.2013-013
   PubMedGoogle Scholar
• Rooney S, McFadyen DA, Wood DL, Moffat DF, Paul PL. Minimally important difference of the fatigue severity scale and modified fatigue impact scale in people with multiple sclerosis. Mult Scler Relat Disord. 2019;35:158–163. doi:10.1016/j.msard.2019.07.028
   PubMed Web of Science ®Google Scholar
• Strober LB, Binder A, Nikelshpur OM, Chiaravalloti N, DeLuca J. The perceived deficits questionnaire: perception, deficit, or distress? Int J MS Care. 2016;18(4):183–190. doi:10.7224/1537-2073.2015-028
   PubMedGoogle Scholar
• Zuur AF, Ieno EN, Walker NJ, Saveliev AA, Smith GM. Mixed Effects Models and Extensions in Ecology with R. Springer; 2009.
   Google Scholar
• McGough JJ, Faraone SV. Estimating the size of treatment effects: moving beyond p values. Psychiatry. 2009;6(10):21–29.
   PubMedGoogle Scholar
• Schumi J, Wittes JT. Through the looking glass: understanding non-inferiority. Trials. 2011;12:106. doi:10.1186/1745-6215-12-106
   PubMed Web of Science ®Google Scholar
• Althunian TA, de Boer A, Groenwold RHH, Klungel OH. Defining the noninferiority margin and analysing noninferiority: an overview. Br J Clin Pharmacol. 2017;83(8):1636–1642. doi:10.1111/bcp.13280
   PubMed Web of Science ®Google Scholar
• Kappos L, Gold R, Arnold DL, et al. Quality of life outcomes with BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: the DEFINE study. Mult Scler. 2014;20(2):243–252. doi:10.1177/1352458513507817
   PubMed Web of Science ®Google Scholar
• Wilken J, Traboulsee A, Nelson F, et al. Longitudinal assessment of neurocognitive function in people with relapsing multiple sclerosis initiating alemtuzumab in routine clinical practice: LEM-COG study results. Mult Scler Relat Disord. 2023;73:104677. doi:10.1016/j.msard.2023.104677
   PubMed Web of Science ®Google Scholar
• Plow M, Packer T, Mathiowetz VG, et al. REFRESH protocol: a non-inferiority randomised clinical trial comparing internet and teleconference to in-person ‘Managing Fatigue’ interventions on the impact of fatigue among persons with multiple sclerosis. BMJ Open. 2020;10(8):e035470. doi:10.1136/bmjopen-2019-035470
   PubMed Web of Science ®Google Scholar
• Horton EJ, Mitchell KE, Johnson-Warrington V, et al. Comparison of a structured home-based rehabilitation programme with conventional supervised pulmonary rehabilitation: a randomised non-inferiority trial. Thorax. 2018;73(1):29–36. doi:10.1136/thoraxjnl-2016-208506
   PubMed Web of Science ®Google Scholar
• Smyth P, Watson KE, Al Hamarneh YN, Tsuyuki RT. The effect of nurse practitioner (NP-led) care on health-related quality of life in people with multiple sclerosis – a randomized trial. BMC Neurol. 2022;22(1):1–275. doi:10.1186/s12883-022-02809-9
   PubMed Web of Science ®Google Scholar
• Akbar N, Turpin K, Petrin J, Smyth P, Finlayson M. A pilot mixed-methods evaluation of MS INFoRm: a self-directed fatigue management resource for individuals with multiple sclerosis. INT J REHABIL RES. 2018;41(2):114–121. doi:10.1097/MRR.0000000000000271
   PubMed Web of Science ®Google Scholar
• Irish AK, Erickson CM, Wahls TL, Snetselaar LG, Darling WG. Randomized control trial evaluation of a modified Paleolithic dietary intervention in the treatment of relapsing-remitting multiple sclerosis: a pilot study. Degener Neurol Neuromuscul Dis. 2017;7:1–18. doi:10.2147/dnnd.S116949
   PubMedGoogle Scholar
• Titcomb TJ, Bostick M, Obeidat AZ. Opinion: the role of the registered dietitian nutritionist in multiple sclerosis care in the United States. Front Neurol. 2023;14:1068358. doi:10.3389/fneur.2023.1068358
   PubMed Web of Science ®Google Scholar
• Strober LB, Becker A, Randolph JJ. Role of positive lifestyle activities on mood, cognition, well-being, and disease characteristics in multiple sclerosis. Applied Neuropsychology: Adult. 2018;25(4):304–311. doi:10.1080/23279095.2018.1458518
   PubMed Web of Science ®Google Scholar
• Marck CH, De Livera AM, Brown CR, et al. Health outcomes and adherence to a healthy lifestyle after a multimodal intervention in people with multiple sclerosis: three year follow-up. PLoS One. 2018;13(5):e0197759. doi:10.1371/journal.pone.0197759
   PubMed Web of Science ®Google Scholar
• Weinstock-Guttman B, Baier M, Park Y, et al. Low fat dietary intervention with omega-3 fatty acid supplementation in multiple sclerosis patients. Prostaglandins Leukot Essent Fatty Acids. 2005;73(5):397–404. doi:10.1016/j.plefa.2005.05.024
   PubMed Web of Science ®Google Scholar
• Kim Y, Lai B, Mehta T, et al. Exercise training guidelines for multiple sclerosis, stroke, and Parkinson disease: rapid review and synthesis. Am J Phys Med Rehabil. 2019;98(7):613–621. doi:10.1097/phm.0000000000001174
   PubMed Web of Science ®Google Scholar
• Kalron A, Dolev M, Greenberg-Abrahami M, et al. Physical activity behavior in people with multiple sclerosis during the COVID-19 pandemic in Israel: results of an online survey. Mult Scler Relat Disord. 2021;47:102603. doi:10.1016/j.msard.2020.102603
   PubMed Web of Science ®Google Scholar
• Matysiak M, Siger M, Walczak A, Ciach A, Jonakowski M, Stasiołek M. The influence of COVID-19 pandemic lockdown on the physical activity of people with multiple sclerosis. The role of online training. Mult Scler Relat Disord. 2022;63:103843. doi:10.1016/j.msard.2022.103843
   PubMed Web of Science ®Google Scholar
• Abasıyanık Z, Kurt M, Kahraman T. COVID-19 and physical activity behaviour in people with neurological diseases: a systematic review. J Dev Phys Disabil. 2022;34(6):987–1012. doi:10.1007/s10882-022-09836-x
   PubMed Web of Science ®Google Scholar
• Weinfurt KP, Reeve BB. Patient-reported outcome measures in clinical research. JAMA. 2022;328(5):472–473. doi:10.1001/jama.2022.11238
   PubMed Web of Science ®Google Scholar
• Riemann-Lorenz K, Eilers M, von Geldern G, Schulz KH, Köpke S, Heesen C. Dietary interventions in multiple sclerosis: development and pilot-testing of an evidence based patient education program. PLoS One. 2016;11(10):e0165246. doi:10.1371/journal.pone.0165246
   PubMed Web of Science ®Google Scholar
• Russell RD, Lucas RM, Brennan V, Sherriff JL, Begley A, Black LJ. Reported changes in dietary behavior following a first clinical diagnosis of central nervous system demyelination. Front Neurol. 2018;9:161. doi:10.3389/fneur.2018.00161
   PubMed Web of Science ®Google Scholar
• Weinstein SM, Reilly E, Garland N, Zimmerman V, Jacobs D. Impact of a virtual wellness program on quality of life measures for patients living with multiple sclerosis during the COVID-19 Pandemic. Int J MS Care. 2022;24(6):282–286. doi:10.7224/1537-2073.2021-134
   PubMedGoogle Scholar